ID: ALA5277990

Max Phase: Preclinical

Molecular Formula: C38H39ClN8O7S

Molecular Weight: 787.30

Associated Items:

Representations

Canonical SMILES:  Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCCNC(=O)COc1cccc3c1C(=O)N(C1CCC(=O)NC1=O)C3O)c1nnc(C)n1-2

Standard InChI:  InChI=1S/C38H39ClN8O7S/c1-19-20(2)55-38-31(19)33(22-9-11-23(39)12-10-22)42-25(34-45-44-21(3)46(34)38)17-29(49)40-15-4-5-16-41-30(50)18-54-27-8-6-7-24-32(27)37(53)47(36(24)52)26-13-14-28(48)43-35(26)51/h6-12,25-26,36,52H,4-5,13-18H2,1-3H3,(H,40,49)(H,41,50)(H,43,48,51)/t25-,26?,36?/m0/s1

Standard InChI Key:  UTOUETFTDAGMCH-UTOGBMEWSA-N

Associated Targets(Human)

Cereblon/Bromodomain-containing protein 4 275 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 787.30Molecular Weight (Monoisotopic): 786.2351AlogP: 3.53#Rotatable Bonds: 12
Polar Surface Area: 197.21Molecular Species: NEUTRALHBA: 12HBD: 4
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.55CX Basic pKa: 4.44CX LogP: 2.37CX LogD: 2.37
Aromatic Rings: 4Heavy Atoms: 55QED Weighted: 0.12Np Likeness Score: -0.76

References

1. Tang P, Zhang J, Liu J, Chiang CM, Ouyang L..  (2021)  Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.,  64  (5.0): [PMID:33616410] [10.1021/acs.jmedchem.0c01487]

Source